Firefly Neuroscience, Inc. (AIFF)
AIFF moved a median of -0.17% 30 minutes after news, and -0.63% by the close. How AIFF actually reacts to news — the realized, point-in-time move the market made, measured across 153 labeled events over the last three years with zero look-ahead.
AIFF’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 41% | 148 |
| 30-min | -0.17% | 48% | 153 |
| 60-min | -0.31% | 44% | 153 |
| to close | -0.63% | 40% | 152 |
| Middle 50% of AIFF reactions | -2.22% to +1.67% |
|---|---|
| Median reaction (30-min) | -0.17% |
| Measured reactions | 153 |
Half of all Firefly Neuroscience, Inc. news events land between -2.22% and +1.67% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when AIFF moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to AIFF's baseline. Nothing else.
Recent AIFF events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Firefly (NASDAQ: AIFF) and NeuroSigma Partner to Expand Access to First FDA-Cleared, Non-Drug Treatment for Pediatric ADHD | Press release | GlobeNewswire | -0.63% | +18.93% | |
| Firefly Neuroscience’s Evoke™ Platform Selected to Bring Objective Brain-Function Insights to Radial’s AI-Native Operating System for Brain Medicine | Press release | GlobeNewswire | +3.92% | +25.49% | |
| Form 8-K FIREFLY NEUROSCIENCE, For: Sep 08 | SEC filing · Form 8-K | SEC EDGAR | +1.93% | -1.96% | |
| Form 10-Q FIREFLY NEUROSCIENCE, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -5.00% | |
| Form 8-K FIREFLY NEUROSCIENCE, For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | — | |
| Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes | Press release | GlobeNewswire | -4.99% | -4.17% | |
| Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee’s Recommendation Backs Broader Access to Key Neuroprotective Peptides | Press release | GlobeNewswire | +0.00% | -3.91% | |
| Form DEF 14A FIREFLY NEUROSCIENCE, For: Aug 05 | SEC filing · Form DEF | SEC EDGAR | +1.50% | +3.33% | |
| Form EFFECT FIREFLY NEUROSCIENCE, | SEC filing · Form EFFECT | SEC EDGAR | +4.13% | +6.61% | |
| Form PRE 14A FIREFLY NEUROSCIENCE, For: Aug 05 | SEC filing · Form PRE | SEC EDGAR | -0.81% | -2.42% | |
| Form 8-K FIREFLY NEUROSCIENCE, For: Jun 25 | SEC filing · Form 8-K | SEC EDGAR | +0.37% | -8.89% | |
| Form S-3/A FIREFLY NEUROSCIENCE, | SEC filing · Form S-3 | SEC EDGAR | -2.12% | -9.16% | |
| Form 8-K FIREFLY NEUROSCIENCE, For: Jun 18 | SEC filing · Form 8-K | SEC EDGAR | +2.27% | -0.76% | |
| Firefly’s AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD | Press release | GlobeNewswire | -1.16% | +2.89% | |
| Form S-3 FIREFLY NEUROSCIENCE, | SEC filing · Form S-3 | SEC EDGAR | -2.74% | +2.44% | |
| Form S-8 FIREFLY NEUROSCIENCE, | SEC filing · Form S-8 | SEC EDGAR | -2.74% | +2.44% | |
| Form 10-Q FIREFLY NEUROSCIENCE, For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -2.14% | -3.74% | |
| Form 8-K FIREFLY NEUROSCIENCE, For: May 06 | SEC filing · Form 8-K | SEC EDGAR | -2.14% | -3.74% | |
| Form 8-K FIREFLY NEUROSCIENCE, For: Apr 16 | SEC filing · Form 8-K | SEC EDGAR | -5.83% | -7.62% | |
| Form D FIREFLY NEUROSCIENCE, | SEC filing · Form D | SEC EDGAR | +1.92% | +5.76% | |
| With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World’s First Known 200,000+ Standardized EEG/ERP Depository | Press release | GlobeNewswire | -1.91% | +1.27% | |
| Form 10-K FIREFLY NEUROSCIENCE, For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -1.85% | +0.93% | |
| Firefly Confirms Public-Private Partnership with the Department of War | Press release | GlobeNewswire | +16.91% | +45.89% | |
| Firefly Announces Discovery of New Brain Wave Biomarkers For Differential Diagnosis of ADHD | Press release | GlobeNewswire | +2.37% | +44.74% | |
| Form D Firefly Neuroscience, | SEC filing · Form D | SEC EDGAR | +2.58% | +19.05% | |
| Form 8-K FIREFLY NEUROSCIENCE, For: Mar 12 | SEC filing · Form 8-K | SEC EDGAR | +2.37% | +44.74% | |
| Anxiety Treatment Boom: GAD Therapies Poised for Multi-Billion Dollar Expansion | Press release | PR Newswire | +0.74% | +5.58% | |
| Firefly Progresses Toward Development and Commercial Launch of its Foundation Model of the Human Brain Powered by NVIDIA GPU Acceleration | Press release | GlobeNewswire | -0.01% | +29.17% | |
| Form 8-K FIREFLY NEUROSCIENCE, For: Feb 03 | SEC filing · Form 8-K | SEC EDGAR | +0.54% | -5.25% | |
| Form 8-K FIREFLY NEUROSCIENCE, For: Dec 16 | SEC filing · Form 8-K | SEC EDGAR | -1.43% | -6.43% | |
| Form EFFECT FIREFLY NEUROSCIENCE, | SEC filing · Form EFFECT | SEC EDGAR | -0.06% | -0.61% | |
| Form S-3 FIREFLY NEUROSCIENCE, | SEC filing · Form S-3 | SEC EDGAR | +0.00% | +4.22% | |
| Form S-8 FIREFLY NEUROSCIENCE, | SEC filing · Form S-8 | SEC EDGAR | +3.97% | +7.95% | |
| Firefly Neuroscience Reports Third Quarter 2025 Financial Results | Press release | GlobeNewswire | +1.21% | +4.82% | |
| Form 10-Q FIREFLY NEUROSCIENCE, For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +1.21% | +4.82% | |
| Form 8-K FIREFLY NEUROSCIENCE, For: Oct 27 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.14% | |
| Form DEFR14A FIREFLY NEUROSCIENCE, | SEC filing · Form DEFR14A | SEC EDGAR | -0.98% | +0.00% | |
| Form DEF 14A FIREFLY NEUROSCIENCE, For: Oct 27 | SEC filing · Form DEF | SEC EDGAR | +1.32% | -2.32% | |
| Form PRE 14A FIREFLY NEUROSCIENCE, For: Oct 31 | SEC filing · Form PRE | SEC EDGAR | -0.68% | -3.06% | |
| Firefly Neuroscience Partners with HealingMaps to Offer Cognitive Electrophysiology Analytics to Over 2,500 Ketamine, Psilocybin, and TMS Clinics Across North America | Press release | GlobeNewswire | +2.56% | +1.83% | |
| Form 8-K FIREFLY NEUROSCIENCE, For: Aug 29 | SEC filing · Form 8-K | SEC EDGAR | +2.60% | -1.49% | |
| Firefly Neuroscience Successfully Deploys NVIDIA L40S GPU Acceleration to Power Next-Gen ‘CLEAR’ Platform | Press release | GlobeNewswire | +5.63% | -10.56% | |
| Form 10-Q FIREFLY NEUROSCIENCE, For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -2.46% | -1.07% | |
| Form EFFECT FIREFLY NEUROSCIENCE, | SEC filing · Form EFFECT | SEC EDGAR | -0.33% | -2.92% | |
| Form S-1 FIREFLY NEUROSCIENCE, | SEC filing · Form S-1 | SEC EDGAR | -0.66% | -0.33% | |
| Firefly Inks Latest Commercial Agreement for Use of its FDA-Cleared BNA™ Platform in Groundbreaking Precision Neuroscience Research | Press release | GlobeNewswire | -4.92% | -7.49% | |
| Firefly Neuroscience to be Added to the Russell Microcap® Index | Press release | GlobeNewswire | +0.00% | +5.15% | |
| Form D FIREFLY NEUROSCIENCE, | SEC filing · Form D | SEC EDGAR | -3.09% | -3.44% | |
| Firefly Neuroscience Researchers Uncover Powerful New Way of Objectively Measuring SCD, MCI, and Dementia in Alzheimer’s Patients | Press release | GlobeNewswire | +2.74% | -24.93% | |
| Form 8-K FIREFLY NEUROSCIENCE, For: Jun 16 | SEC filing · Form 8-K | SEC EDGAR | +0.65% | -3.27% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the AIFF section they belong to.
Where else AIFF is measured.
AIFF earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Firefly Neuroscience, Inc.'s median reaction calculated?
Every labeled AIFF news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 153 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 48% of AIFF's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does AIFF's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.